Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001437 |
---|---|
Receipt number | R000001745 |
Scientific Title | Phase II study of FOLFIRI plus Bevacitumab in the treatment of Japanese patients with advanced colorectal cancer. |
Date of disclosure of the study information | 2008/10/20 |
Last modified on | 2013/08/23 09:11:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/10/18 11:02:02 | ||
2 | Update | 2010/07/27 16:39:28 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
3 | Update | 2011/03/19 18:22:10 | Email |
|
4 | Update | 2011/10/18 10:01:27 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2012/04/18 10:07:33 | Date trial data considered complete Date analysis concluded |
|
6 | Update | 2013/08/23 09:10:32 | Email |
|
7 | Update | 2013/08/23 09:11:14 | Recruitment status Publication of results |